Vinod Pullarkat

43PUBLICATIONS
123CO-AUTHORS
Haematological tumoursTransplantation immunologyHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 24, 2026
B-cell activating factor receptor expression in B-lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy.

|Jul 23, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

|Sep 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.

Jose Tinajero, Kim Nguyen, Dat Ngo

|Sep 05, 2025
Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model.

Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux

|Aug 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Timothy E O'Connor, Chenyu Lin, Gregory W Roloff

Pageof 8

Frequent Collaborators

20 joint publications

Ibrahim Aldoss

12 joint publications

Monzr M Al Malki

11 joint publications

Ryotaro Nakamura

10 joint publications

Amandeep Salhotra